Last but not least @COH_RadOnc’s Dr. Han providing a succinct summary of our experience with #BgRT, followed by a great talk from Dr. Chen @ Yale RadOnc optimizing new pet metrics to assess patient eligibility for #SCINTIX. Let’s keep these coming!

Our very own PGY-3 Dr. Pule Wang sharing our experience of 10 patients with osseous mets treated with #SCINTIX. 100% of patients with partial/complete response & major reductions in PET activity following #BgRT. Nice job Dr. Wang and Dr. Watkins! @COH_RadOnc @reflexionmed

Happening now! @reflexionmed ‘s Cross-site SCINTIX workshop. Nice talks by @DocGlaser and Yufei Liu from @COH_RadOnc and many others from Yale, UT-SW as we seek to improve our understanding of how best to implement and improve #BgRT.

Dr. Chenyang Shen giving a talk titled, "Experience of SCINTIX Biology-Guided Radiotherapy for Lung Cancer Treatment and Beyond," at the #AAPM2025 RefleXion Luncheon.

Sam Mazin, Phd, RefleXion's founder and CTO, joins the Medical Physics Institute's Physicians and Administrators Technology day to talk about the RefleXion X1 platform with SCINTIX therapy! #AAPM2025 #SCINTIX #radiotherapy

This month, we bring awareness to sarcoma and bone cancer, and we honor survivors and those undergoing treatment. Cleared to treat tumors in the lung and bone, SCINTIX therapy is a promising new option for patients with bone cancer. #RefleXion #CancerAwareness #BoneCancerAwareness #BoneCancer #SarcomaAwareness #SarcomaCancer #BoneCancerAwarenessMonth #SarcomaAwarnessMonth #osteosarcoma

Our newest cancer treatment and imaging center in 🌊 Newport Beach offers advanced radiation therapies — including SCINTIX — just minutes away from your community. Learn more: lat.ms/4dNQ4UO

The RefleXion X1 with SCINTIX therapy is the only hybrid platform that offers both breakthrough biologic and best-in-class anatomic capabilities to treat solid tumors of any stage. #SCINTIX #RefleXion #CancerTreatment #CancerTech

Congratulations to the Newport Beach @KeckMedicineUSC RadOnc team on treating their first patient with SCINTIX biology-guided radiotherapy!

Congratulations to @uscnorris on opening your new, state-of-the-art facility in Newport Beach! The RefleXion X1 looks great in its new home. We are thrilled to see SCINTIX biology-guided radiotherapy become available to more patients throughout Orange County! #cancercare #cancertreatment #SCINTIX news.keckmedicine.org/usc-no…

(2/3) enabling physicians to combine SCINTIX BgRT with conventional SBRT seamlessly. This achievement marks another significant step toward our mission of providing personalized and precision radiation therapy for our cancer patients.

Not all adaptive radiotherapy delivery requires a new treatment plan. In a recent clinical case, SCINTIX therapy maintained a tracked dose to the PET avid portion of the PTV, adjusting to decreases in target size autonomously. No workflow interruption. No need for replanning. Just breakthrough technology performing as designed with the added benefit of accretive reimbursement.

We are excited to announce the initiation of the BIOGUIDE-X2 clinical study to expand indications for SCINTIX biology-guided radiotherapy at Hackensack Meridian John Theurer Cancer. Read more in our press release bit.ly/4a5ucm9

(2/2) Dr. Desai and Dr. Cai are co-PIs of this trial evaluating the feasibility of imaging and SCINTIX planning for patients injected with Ga68-PSMA-11 on the PET-linac platform. This milestone highlights SCINTIX therapy's versatility, advancing PET-guided RT with novel tracers.

Top 5 @AcceleratorsRO of the year, starting with #5. We hosted the CTO and CMO of @reflexionmed to talk about SCINTIX biology guided radiotherapy for bone and lung metastases. Great discussion around this machine! Sam and Sean are good career role models for #RadOnc, too.

Susanne's doctors are using our SCINTIX therapy as part of a breakthrough treatment plan for her non-small cell lung cancer. We're all with you, Susanne! ❤️ Read more about her experience and how SCINTIX is providing her with more options: bit.ly/3Y2BrH2 🧬

We are excited to announce that SCINTIX therapy has been granted G-codes from the Centers for Medicare and Medicaid (CMS). These new codes now allow for payment in both freestanding and hospital outpatient settings. This decision expands access to SCINTIX therapy for the 40% of patients who receive radiotherapy treatment in freestanding centers. Visit scintixtherapy.com to learn more about this groundbreaking cancer treatment.

While delivering a SCINTIX treatment to a bone lesion, an 8.6mm patient shift during treatment was reported. Because SCINTIX therapy delivers a tracked dose, it autonomously followed the tumor and delivered the treatment as planned. A typical image-guided SBRT PTV margin would have missed the inferior edge of the tumor. Managing motion - especially unexpected motion - is an ongoing challenge. SCINTIX therapy, currently approved for lung and bone tumors, solves the conundrum of tumor motion. Contact us to learn more. bit.ly/3SCwP6i #SCINTIX therapy #clinicalhighlight #BgRT #trackeddose #cancertreatment

Most patients with stage four cancer are not considered candidates for definitive radiotherapy. The good news? Our breakthrough SCINTIX therapy creates a new option for patients with lung or bone tumors arising from primary or metastatic cancer. #RefleXion #CancerTherapy #CancerTreatment #CancerAwareness #CancerTech

It was a great visit to the @reflexionmed headquarters, can't wait to start SCINTIX BGRT at @KeckMedicineUSC to fight #cancer ! ✌🏻